Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ThermoGenesis Holdings is a leading developer of automated cell processing technologies and a provider of contract development and manufacturing organization (CDMO) services for the cell and gene therapy industry. The company's proprietary CAR-TXpress platform streamlines the manufacturing of CAR-T cells by automating cell isolation, purification, and washing. Their product portfolio includes the AXP Cell Processing System for cord blood and the BioArchive System for cryogenic storage. Recently, the company has expanded into providing end-to-end CDMO services to support biotech firms in the development of advanced cell-based therapies. Headquartered in Rancho Cordova, California, ThermoGenesis focuses on providing high-efficiency, GMP-compliant solutions to accelerate the delivery of regenerative medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ThermoGenesis Holdings.